Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo.

Saved in:

Bibliographic Details
Title:	Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo.
Authors:	Lopez-Lopez E; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Autry RJ; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Smith C; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Yang W; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Paugh SW; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Panetta JC; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Crews KR; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Bonten EJ; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Smart B; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Pei D; Department of Biostatistics., McCorkle JR; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Diouf B; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Roberts KG; Hematological Malignancies Program, and.; Department of Pathology, and., Shi L; Department of Biostatistics., Pounds S; Department of Biostatistics., Cheng C; Department of Biostatistics., Mullighan CG; Hematological Malignancies Program, and.; Department of Pathology, and., Pui CH; Hematological Malignancies Program, and.; Department of Pathology, and.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Relling MV; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Evans WE; Hematological Malignancies Program, and.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Source:	The Journal of clinical investigation [J Clin Invest] 2020 Dec 01; Vol. 130 (12), pp. 6600-6615.
Publication Type:	Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1558-8238
DOI:	10.1172/JCI140797